Bellevue Asset Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bellevue Asset Management’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$31.8K	Hold	200	–	–	0.01%	220
2026 Q1	$25.6K	Hold	200	–	–	0.01%	226
2025 Q4	$24.5K	Hold	200	–	–	0.01%	220
2025 Q3	$20K	Hold	200	–	–	0.01%	230
2025 Q2	$16.6K	Hold	200	–	–	0.01%	248
2025 Q1	$16.2K	Hold	200	–	–	0.01%	242
2024 Q4	$18K	Hold	200	–	–	0.01%	241
2024 Q3	$19.8K	Hold	200	–	–	0.01%	228
2024 Q2	$18.5K	Hold	200	–	–	0.01%	230
2024 Q1	$19K	Hold	200	–	–	0.01%	225
2023 Q4	$17.9K	Hold	200	–	–	0.02%	232
2023 Q3	$14.6K	Hold	200	–	–	0.01%	237
2023 Q2	$16.6K	Hold	200	–	–	0.01%	233
2023 Q1	$15.2K	Hold	200	–	–	0.01%	244
2022 Q4	$16.3K	Hold	200	–	–	0.01%	244
2022 Q3	$16K	Hold	200	–	–	0.01%	253
2022 Q2	$15K	Hold	200	–	–	0.01%	267
2022 Q1	$18K	Sell	200 -150	-43%	-$13.9K	0.01%	268
2021 Q4	$39K	Hold	350	–	–	0.02%	204
2021 Q3	$44K	Sell	350 -53	-13%	-$6.83K	0.03%	189
2021 Q2	$55K	Sell	403 -200	-33%	-$26.3K	0.03%	169
2021 Q1	$82K	Hold	603	–	–	0.05%	138
2020 Q4	$94K	Hold	603	–	–	0.06%	118
2020 Q3	$67K	Hold	603	–	–	0.05%	134
2020 Q2	$68K	Hold	603	–	–	0.07%	132
2020 Q1	$60K	Hold	603	–	–	0.06%	148
2019 Q4	$57K	Buy	+603	New	+$52.2K	0.04%	138

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

Bellevue Asset Management's XBI Position: Q2 2026 in Review

Bellevue Asset Management held its State Street SPDR S&P Biotech ETF (XBI) position steady in Q2 2026 at 200 shares worth $31.8K. The position accounts for 0.01% of the portfolio, ranked #220.

Bellevue Asset Management first reported a position in XBI in Q4 2019 and has held it in 27 quarters since. The position peaked at $94K in Q4 2020. 936 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

Bellevue Asset Management held 200 shares of State Street SPDR S&P Biotech ETF worth $31.8K as of Q2 2026.
Bellevue Asset Management left its State Street SPDR S&P Biotech ETF share count unchanged in Q2 2026.
State Street SPDR S&P Biotech ETF made up 0.01% of Bellevue Asset Management's portfolio in Q2 2026, its #220 holding.
Bellevue Asset Management first reported a position in State Street SPDR S&P Biotech ETF in Q4 2019 and has held it in 27 quarters since.
Bellevue Asset Management's State Street SPDR S&P Biotech ETF position peaked at $94K in Q4 2020.
936 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Bellevue Asset Management's 13F filing for Q2 2026, filed 4 Aug 2026.